한글목차

알레르기 면역요법 세계 시장은 2025년에 27억 4,060만 달러, 2032년에는 52억 7,650만 달러에 달할 것으로 예측되며, 2025-2032년간 연평균 9.8%의 성장률을 보일 것으로 예상됩니다.

그림. 2025년 지역별 알레르기 면역요법 시장 점유율(%)

알레르기 면역요법은 일반적으로 알레르기 주사 또는 감작 주사로 알려져 있으며, 특정 알레르기에 대한 의학적 치료를 말합니다. 이 치료법은 알레르기 반응으로 인한 증상을 완화하기 위해 알레르기 항원의 양을 점차적으로 증가시켜 알레르기 반응을 완화하는 것을 목표로 합니다. 이 치료법은 의사의 감독하에 엄격하게 시행됩니다. 조절된 양의 알레르겐을 투여함으로써 면역 요법은 시간이 지남에 따라 증상을 완화하는 데 도움이 됩니다. 확인된 알레르겐에 대한 민감성을 감소시켜 약수처리의 필요성을 줄이는 것을 목표로 합니다. 치료 기간은 개인의 반응에 따라 다르지만 보통 3-5년 정도이며, 치료 종료 시 장기적인 증상 완화를 기대할 수 있습니다.

시장 역학

세계 알레르기 면역요법 시장의 성장은 주로 전 세계 알레르기 질환의 유병률 증가에 기인합니다. 알레르기성 비염과 천식은 가장 흔하게 관찰되는 만성 건강 문제 중 하나입니다. 환경오염의 확대와 생활습관의 변화가 알레르기 확산에 기여하고 있습니다. 알레르기 질환의 정확한 진단과 관리에 대한 엄격한 규제 지침은 면역 치료의 조기 도입을 더욱 촉진하고 있습니다. 내약성이 개선되고 효과가 빠르게 발현되는 설하 및 피하 알레르기 백신의 개발은 시장 개척의 기회로 작용하고 있습니다. 재조합 항원 기술의 채택과 환자 개개인에 맞는 알레르기 항원 추출물의 맞춤화는 R&D 이니셔티브에 박차를 가하는 주요 트렌드입니다. 그러나 치료 기간이 길어지는 데 따른 높은 비용과 신흥국 시장에서의 낮은 인지도는 시장 개척에 걸림돌이 될 수 있습니다.

본 조사의 주요 특징

• 세계의 알레르기 면역요법(Allergy Immunotherapy) 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(백만 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 세계 알레르기 면역요법 시장의 주요 기업들을 기업 개요, 제품 포트폴리오, 주요 특징, 성과, 전략 등의 매개변수를 기반으로 프로파일링합니다.
• 주요 기업으로는 Stallergenes Greer,ALK-Abello A/S,Allergy Therapeutics,Allergopharma,HAL Allergy Group,Aimmune Therapeutics,DBV Technologies,Leti Pharma,Jubilant HollisterStier,Merck KGaA,Biomay AG,Hollister Allergy,Aravax Pty Ltd,Allovate, LLC 등이 있습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 알레르기 면역요법 세계 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 알레르기 면역요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 제조업체 매출
• 인수와 제휴 시나리오
• 제품 발매/승인
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 알레르기 면역요법 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 알레르기 면역요법 시장, 치료 유형별, 2020-2032년,(100만 달러)

• 서론
• 피하 면역치료(SCIT)
• 설하 면역치료(SLIT)

제6장 세계의 알레르기 면역요법 시장, 알레르기 유형별, 2020-2032년,(100만 달러)

• 서론
• 알레르기성 비염
• 알레르기성 천식
• 음식 알레르기
• 독 알레르기
• 기타

제7장 세계의 알레르기 면역요법 시장, 유통 채널별, 2020-2032년,(100만 달러)

• 서론
• 병원 약국
• 소매 약국
• 온라인 약국

제8장 세계의 알레르기 면역요법 시장, 지역별, 2020-2032년,(100만 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Stallergenes Greer
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Allergopharma
  • HAL Allergy Group
  • Aimmune Therapeutics
  • DBV Technologies
  • Leti Pharma
  • Jubilant HollisterStier
  • Merck KGaA
  • Biomay AG
  • Hollister Allergy
  • Aravax Pty Ltd
  • Allovate, LLC

제10장 애널리스트 추천 사항

• 융성과 쇠퇴
• Coherent Opportunity Map

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Allergy Immunotherapy Market is estimated to be valued at USD 2,740.6 Mn in 2025 and is expected to reach USD 5,276.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Figure. Allergy Immunotherapy Market Share (%), By Region 2025

Allergy immunotherapy, commonly known as allergy shots or desensitization injections, refer to a medical treatment for certain allergies. It involves exposing people to gradually increasing amounts of allergen(s), with goal of decreasing the symptoms caused by the allergic response. The therapy is strictly administered under a physician's supervision. By administering controlled amounts of allergens, immunotherapy can lead to reduction in symptoms over time. It aims to reduce sensitivity to the identified allergens and lessen the patient's need for medication. The treatment usually spans 3-5 years depending on the individual's response and may provide long lasting relief from symptoms upon completion of therapy.

Market Dynamics:

Global allergy immunotherapy market growth is primarily driven by rising prevalence of allergic diseases globally. Allergic rhinitis and asthma are among the most common observed chronic health issues. Growing environmental pollution and changing lifestyle factors have contributed to the allergy epidemic. Stringent regulatory guidelines for accurate diagnosis and management of allergic disorders further aid early adoption of immunotherapy. Development of sublingual and subcutaneous allergy vaccines with improved tolerability and faster onset of action can provide opportunities for the market growth. Adoption of recombinant antigen technologies and customized allergen extracts tailored to individual patients are key trends spurring R&D initiatives. However, high costs associated with prolonged therapy and lack of awareness in developing nations can hamper the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global allergy immunotherapy market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global allergy immunotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this includes Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, Jubilant HollisterStier, Merck KGaA, Biomay AG, Hollister Allergy, Aravax Pty Ltd, Allovate, LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global allergy immunotherapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy immunotherapy market

Detailed Segmentation-

• By Treatment Type:
  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
  • 10-30 MeV
  • 30 -70 MeV
• By Allergy Type:
  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Venom Allergy
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Stallergenes Greer
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Allergopharma
  • HAL Allergy Group
  • Aimmune Therapeutics
  • DBV Technologies
  • Leti Pharma
  • Jubilant HollisterStier
  • Merck KGaA
  • Biomay AG
  • Hollister Allergy
  • Aravax Pty Ltd
  • Allovate, LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Allergy Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Allergy Immunotherapy Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Allergy Immunotherapy Market, By Treatment Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Subcutaneous Immunotherapy (SCIT)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Sublingual Immunotherapy (SLIT)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • 10-30 MeV
  • 30 -70 MeV

6. Global Allergy Immunotherapy Market, By Allergy Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Allergic Rhinitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Allergic Asthma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Food Allergy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Venom Allergy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Allergy Immunotherapy Market, By Distribution Channel, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Allergy Immunotherapy Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Stallergenes Greer*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ALK-Abello A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Allergy Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Allergopharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • HAL Allergy Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Aimmune Therapeutics
  • DBV Technologies
  • Leti Pharma
  • Jubilant HollisterStier
  • Merck KGaA
  • Biomay AG
  • Hollister Allergy
  • Aravax Pty Ltd
  • Allovate, LLC

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact